Search results
German Merck’s MS drug falls short in pair of Phase 3 tests
BioPharma Dive via Yahoo Finance· 5 months agoDive Brief: An emerging class of drugs under development to treat multiple sclerosis suffered...
Merck KGaA suffers major blow as MS drug fails in late-stage trials
Reuters via AOL· 5 months agoFRANKFURT (Reuters) -Merck KGaA's experimental multiple sclerosis (MS) drug missed the primary goal...
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
Benzinga via Yahoo Finance· 11 months agoRoche Holdings AG's (OTC: RHHBY) Phase 2 FENopta study of oral fenebrutinib for relapsing forms of...
Roche's (RHHBY) MS Drug Reduces Brain Lesions in Phase II Study
Zacks via Yahoo Finance· 6 months agoRoche (RHHBY) presents new data from a phase II study, which shows that fenebrutinib is brain...
What Is the First Line of Treatment for Multiple Sclerosis?
Verywell Health via Yahoo News· 2 years agoMedically reviewed by Lindsay Cook, PharmD In multiple sclerosis (MS), the immune system attacks the...
Not All Forms Of Multiple Sclerosis Have The Same Symptoms
Women's Health via Yahoo News· 2 years agoThere are actually four distinct types of MS including clinically isolated syndrome,...
Novartis' (NVS) Sandoz Gets FDA Nod for Tysabri's Biosimilar
Zacks via Yahoo Finance· 8 months agoNovartis’ NVS generic arm, Sandoz, announced that the FDA approved Tyruko (natalizumab-sztn), a...
Roche says new MS drug shown to reduce brain lesions
Reuters via Yahoo News· 11 months agoRoche said on Wednesday that its multiple sclerosis drug candidate, part of a class of compounds that has been linked to cases of liver damage, reduced...
Resetting immune system with stem cells could treat common form of MS – study
Press Association News via AOL· 7 months agoA therapy normally used to treat blood cancers by “resetting” the immune system could slow the...
Early treatment could slow the onset of multiple sclerosis symptoms, study finds
NBC News via Yahoo News· 1 year agoStarting treatment for multiple sclerosis early — before symptoms even begin — could possibly delay...